Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GENinCode UK Ltd. (GB:GENI)
LSE:GENI
Holding GB:GENI?
Track your performance easily
GENI Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range3.34p - 12.00p
Previous Close6.75p
Volume17.04K
Average Volume (3M)127.69K
Market Cap
£11.95M
Enterprise Value9.76M
Total Cash (Recent Filing)£2.48M
Total Debt (Recent Filing)£299.00K
Price to Earnings (P/E)―
Beta1.34
Next Earnings
Sep 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding176,960,000
10 Day Avg. Volume25,891
30 Day Avg. Volume127,686
Standard Deviation0.26
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)675.00
Price to Sales (P/S)5.53
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GENinCode UK Ltd. News
PremiumCompany Announcements
GENinCode Advances Heart Disease Detection with New Partnership
PremiumCompany Announcements
GENinCode to Unveil Mid-Year Financial ResultsPremiumCompany Announcements
GENinCode Advances CHD Risk Prediction
PremiumCompany Announcements
GENinCode Plc AGM Success, Advances Prevention
PremiumCompany Announcements
GENinCode Plc Announces Annual Report and AGM
PremiumCompany Announcements
GENinCode Reports Growth and US Expansion
PremiumCompany Announcements
GENinCode Announces Upcoming Financial ResultsPremiumCompany Announcements
GENinCode’s Breakthrough in CHD Risk PredictionOptions Prices
Currently, No data available
---
Ownership Overview
18.09% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
81.91% Public Companies and
Individual Investors
GENI FAQ
What was GENinCode UK Ltd.’s price range in the past 12 months?
GENinCode UK Ltd. lowest share price was 3.34p and its highest was 12.00p in the past 12 months.
What is GENinCode UK Ltd.’s market cap?
Currently, no data Available
When is GENinCode UK Ltd.’s upcoming earnings report date?
GENinCode UK Ltd.’s upcoming earnings report date is Sep 25, 2024 which is in 5 days.
How were GENinCode UK Ltd.’s earnings last quarter?
GENinCode UK Ltd. released its earnings results on Jun 03, 2024. The company reported -0.037p earnings per share for the quarter, missing the consensus estimate of -0.033p by -0.004p.
Is GENinCode UK Ltd. overvalued?
According to Wall Street analysts GENinCode UK Ltd.’s price is currently Overvalued.
Does GENinCode UK Ltd. pay dividends?
GENinCode UK Ltd. does not currently pay dividends.
What is GENinCode UK Ltd.’s EPS estimate?
GENinCode UK Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GENinCode UK Ltd. have?
GENinCode UK Ltd. has 176,964,430 shares outstanding.
What happened to GENinCode UK Ltd.’s price movement after its last earnings report?
GENinCode UK Ltd. reported an EPS of -0.037p in its last earnings report, missing expectations of -0.033p. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of GENinCode UK Ltd.?
Currently, no hedge funds are holding shares in GB:GENI
---
GENinCode UK Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-41.30%
12-Months-Change
Fundamentals
Return on Equity
-152.70%
Trailing 12-Months
Asset Growth
-64.52%
Trailing 12-Months
Company Description
GENinCode UK Ltd.
GENinCode PLC is engaged in the risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode.
---
GENI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering GENI
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-41.30%
reiterated a buy rating a year ago
Copying Max Herrmann's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -41.30% per trade.
---